TAK-279 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-02-17 in 4mo
ESTIMATED |
READOUT
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the B
Phase 2 · Crohn's Disease |
TAK TAKEDA PHARMACEUTICAL CO LTD | TAK-279 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-20
Sponsor-projected date — can change
|